Denusta, Justine S.
HRN: 26-99-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2025
CLOXACILLIN 250MG/5ML, 60ML SUSPENSION (BOT)
04/20/2025
04/27/2025
ORAL
10ml
Q6
Lacerated Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes